Astellas Submits Application For Vesicare Oral Disintegration Tablets
This article was originally published in PharmAsia News
Executive Summary
To maximum product value, Astellas Dec. 22 submitted an approval application for overactive bladder drug Vesicare (solifenacin) oral disintegration tablets in Japan